Fonda Liu
Impact in
-
- Multiple Sclerosis Research Studies
-
- Neurogenesis and neuroplasticity mechanisms
Papers in
-
- Alzheimer's disease research and treatments 5
-
- Sphingolipid Metabolism and Signaling 1
- Amyloidosis: Diagnosis, Treatment, Outcomes 1
- Co-authors
- Bingbing Li (1 shared paper)Dieter A. Häring (1 shared paper)Hans‐Peter Hartung (1 shared paper)Bernard M.J. Uitdehaag (1 shared paper)Martin Merschhemke (1 shared paper)Ludwig Kappos (1 shared paper)Catherine Lubetzki (1 shared paper)Jerry S. Wolinsky (1 shared paper)
- Journals
- Alzheimer s & Dementia (4 papers)Alzheimer s & Dementia Translational Research & Clinical Interventions (2 papers)The Lancet Healthy Longevity (1 paper)Neurology (1 paper)The Lancet (1 paper)
- Partner nations
- United StatesSwitzerlandSpain
In The Last Decade
Fonda Liu
8 papers receiving 452 citations
Fonda Liu's Hit Papers
Peers
Comparison fields: 5 of 62
- Pathology and Forensic Medicine 275
- Developmental Neuroscience 35
- Neurology 112
- Neurology 60
- Rheumatology 71
Countries citing papers authored by Fonda Liu
This map shows the geographic impact of Fonda Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fonda Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fonda Liu more than expected).
Fields of papers citing papers by Fonda Liu
This network shows the impact of papers produced by Fonda Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fonda Liu. The network helps show where Fonda Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fonda Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2016 | 335 |
| 2 | 2019 | 79 | |
| 3 | 2019 | 27 | |
| 4 | 2024 | 6 | |
| 5 | 2020 | 6 | |
| 6 | 2020 | 2 | |
| 7 | 2019 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2025 | 0 |
About Fonda Liu
Fonda Liu is a scholar working on Physiology, Molecular Biology, Pharmacology, Psychiatry and Mental health and Pathology and Forensic Medicine, having authored 9 papers that have together received 457 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (5 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Dementia and Cognitive Impairment Research (2 papers), Sphingolipid Metabolism and Signaling (1 paper), Epilepsy research and treatment (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper), Multiple Sclerosis Research Studies (1 paper) and Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (275 citations), Developmental Neuroscience (35 citations), Neurology (112 citations), Neurology (60 citations) and Rheumatology (71 citations). Fonda Liu has collaborated with scholars based in United States, Switzerland and Spain. Frequent co-authors include Bingbing Li, Dieter A. Häring, Hans‐Peter Hartung, Bernard M.J. Uitdehaag, Martin Merschhemke, Ludwig Kappos, Catherine Lubetzki, Jerry S. Wolinsky, Fred Lublin and Mark S. Freedman. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s & Dementia Translational Research & Clinical Interventions, The Lancet Healthy Longevity, Neurology and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.